In breast cancer (MCF-7, MDA-MB-231 and BT-474) inhibits proliferation, migration and G1/S cell cycle progression through suppression of Hepatocyte Growth Factor (HGF)-induced c-Met activation, without affecting non-tumorous cells (MCF10). This evidence concerns the gene HGF and breast carcinoma.